Seilern Investment Management Ltd Sells 31,274 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Seilern Investment Management Ltd lowered its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 19.8% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 126,817 shares of the medical equipment provider's stock after selling 31,274 shares during the period. Intuitive Surgical accounts for approximately 4.1% of Seilern Investment Management Ltd's investment portfolio, making the stock its 15th biggest holding. Seilern Investment Management Ltd's holdings in Intuitive Surgical were worth $62,809,000 at the end of the most recent reporting period.

Other large investors also recently made changes to their positions in the company. Atala Financial Inc bought a new position in Intuitive Surgical during the 4th quarter worth $25,000. Parvin Asset Management LLC bought a new position in Intuitive Surgical during the fourth quarter worth about $26,000. Global Financial Private Client LLC increased its position in Intuitive Surgical by 253.3% during the first quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider's stock worth $26,000 after acquiring an additional 38 shares during the period. BankPlus Trust Department bought a new position in Intuitive Surgical during the fourth quarter worth about $28,000. Finally, Hurley Capital LLC acquired a new stake in shares of Intuitive Surgical in the fourth quarter valued at approximately $28,000. Institutional investors own 83.64% of the company's stock.

Intuitive Surgical Price Performance

ISRG opened at $557.08 on Friday. Intuitive Surgical, Inc. has a fifty-two week low of $413.52 and a fifty-two week high of $616.00. The firm has a market capitalization of $199.67 billion, a price-to-earnings ratio of 86.91, a PEG ratio of 5.85 and a beta of 1.67. The company's 50 day moving average price is $521.99 and its two-hundred day moving average price is $539.24.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, topping the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. The company had revenue of $2.25 billion for the quarter, compared to analysts' expectations of $2.19 billion. During the same quarter in the previous year, the firm posted $1.50 earnings per share. As a group, equities research analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on the stock. Robert W. Baird dropped their price target on shares of Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating for the company in a research report on Wednesday, April 23rd. Truist Financial dropped their price target on Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating for the company in a research note on Wednesday, April 23rd. BTIG Research set a $560.00 price target on Intuitive Surgical and gave the company a "buy" rating in a research note on Monday, April 14th. Evercore ISI decreased their price objective on shares of Intuitive Surgical from $510.00 to $470.00 and set an "in-line" rating on the stock in a research note on Wednesday, April 23rd. Finally, Piper Sandler decreased their price objective on shares of Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 23rd. Four analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $596.05.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, EVP Robert Desantis sold 11,545 shares of the company's stock in a transaction dated Thursday, March 13th. The stock was sold at an average price of $499.22, for a total value of $5,763,494.90. Following the sale, the executive vice president now owns 5,224 shares in the company, valued at approximately $2,607,925.28. The trade was a 68.85% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, SVP Mark Brosius sold 216 shares of the company's stock in a transaction that occurred on Friday, June 6th. The shares were sold at an average price of $563.11, for a total value of $121,631.76. Following the completion of the sale, the senior vice president now owns 907 shares in the company, valued at $510,740.77. The trade was a 19.23% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 25,443 shares of company stock worth $12,692,195. Insiders own 0.70% of the company's stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.